DANIEL K. SPIEGELMAN - 01 Jun 2023 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Director
Signature
By: Justin Hunter For: Daniel K. Spiegelman
Issuer symbol
MYGN
Transactions as of
01 Jun 2023
Net transactions value
-$198,760
Form type
4
Filing time
02 Jun 2023, 18:15:32 UTC
Previous filing
26 May 2023
Next filing
07 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $0 +15,151 +45% $0.000000 49,131 01 Jun 2023 Direct F1
transaction MYGN Common Stock Sale $198,760 -8,638 -18% $23.01 40,493 02 Jun 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant.
F2 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney